ARTICLE
27 April 2023

Emma And Rebekah Talk IP: No Deal! ACCC Views On Pharma Patent Dispute Settlement (Podcast)

In this podcast series, Australian partners Rebekah Gay and Emma Iles explore a variety of topics, issues and areas of intellectual property law.
Australia Intellectual Property
To print this article, all you need is to be registered or login on Mondaq.com.

In this podcast series, Australian partners Rebekah Gay and Emma Iles explore a variety of topics, issues and areas of intellectual property law.

In episode 18, Emma and Rebekah are joined by Patrick Gay, a Partner in Herbert Smith Freehills' Competition, Regulation & Trade team. Together they unpack the ACCC's 2022 draft determination which proposed to deny authorisation of a settlement and licence agreement that was intended to resolve an ongoing patent dispute in the Federal Court between Celgene and generic drug companies Juno and Natco. With Patrick's insights, Emma and Rebekah touch on the potential impacts of the draft determination on parties looking to settle IP disputes in the future.

For more in the series of Emma and Rebekah talk IP podcasts click here.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

ARTICLE
27 April 2023

Emma And Rebekah Talk IP: No Deal! ACCC Views On Pharma Patent Dispute Settlement (Podcast)

Australia Intellectual Property

Contributor

See More Popular Content From

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More